1. Home
  2. MGLD vs EDAP Comparison

MGLD vs EDAP Comparison

Compare MGLD & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGLD
  • EDAP
  • Stock Information
  • Founded
  • MGLD 1996
  • EDAP 1979
  • Country
  • MGLD United States
  • EDAP France
  • Employees
  • MGLD N/A
  • EDAP N/A
  • Industry
  • MGLD Finance/Investors Services
  • EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • MGLD Finance
  • EDAP Health Care
  • Exchange
  • MGLD Nasdaq
  • EDAP Nasdaq
  • Market Cap
  • MGLD 44.8M
  • EDAP 46.7M
  • IPO Year
  • MGLD N/A
  • EDAP 1997
  • Fundamental
  • Price
  • MGLD $1.04
  • EDAP $2.45
  • Analyst Decision
  • MGLD
  • EDAP Buy
  • Analyst Count
  • MGLD 0
  • EDAP 3
  • Target Price
  • MGLD N/A
  • EDAP $8.50
  • AVG Volume (30 Days)
  • MGLD 15.1K
  • EDAP 177.9K
  • Earning Date
  • MGLD 11-07-2025
  • EDAP 11-06-2025
  • Dividend Yield
  • MGLD N/A
  • EDAP N/A
  • EPS Growth
  • MGLD N/A
  • EDAP N/A
  • EPS
  • MGLD N/A
  • EDAP N/A
  • Revenue
  • MGLD $31,205,000.00
  • EDAP $74,008,221.00
  • Revenue This Year
  • MGLD N/A
  • EDAP N/A
  • Revenue Next Year
  • MGLD N/A
  • EDAP N/A
  • P/E Ratio
  • MGLD N/A
  • EDAP N/A
  • Revenue Growth
  • MGLD N/A
  • EDAP 1.56
  • 52 Week Low
  • MGLD $0.64
  • EDAP $1.21
  • 52 Week High
  • MGLD $2.10
  • EDAP $3.29
  • Technical
  • Relative Strength Index (RSI)
  • MGLD 57.88
  • EDAP 63.15
  • Support Level
  • MGLD $1.01
  • EDAP $2.33
  • Resistance Level
  • MGLD $1.15
  • EDAP $2.85
  • Average True Range (ATR)
  • MGLD 0.08
  • EDAP 0.29
  • MACD
  • MGLD 0.01
  • EDAP 0.05
  • Stochastic Oscillator
  • MGLD 65.62
  • EDAP 65.71

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

Share on Social Networks: